Kazlauskaitė P

ORCID: 0009-0004-9596-9750 · 2 papers in corpus

2026

Development and validation of gene expression-based signature for high-grade serous ovarian cancer.

Journal of ovarian research ·doi:10.1186/s13048-026-01989-z

BACKGROUND: High-grade serous ovarian cancer (HGSOC) is the second most lethal gynecologic malignancy, often diagnosed at a late stage due to the lack of reliable early detection strategies. Currently, there are no specific diagnostic or pr…

2025

Integrative Analysis of Gene Expression and Promoter Methylation to Differentiate High-Grade Serous Ovarian Cancer from Benign Tumors.

Biomedicines ·doi:10.3390/biomedicines13020441

Background: Ovarian cancer (OC) is the third most common and second most lethal onco-gynecological disease in the world, with high-grade serous ovarian cancer (HGSOC) making up the majority of OC cases worldwide. The current serological bio…